{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:49:36Z","timestamp":1788871776775,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK090728"],"award-info":[{"award-number":["P30DK090728"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["P30DK084567"],"award-info":[{"award-number":["P30DK084567"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1053\/j.gastro.2011.11.036","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T16:57:47Z","timestamp":1323363467000},"page":"622-633.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Inhibition of Cdc25A Suppresses Hepato-renal Cystogenesis in Rodent Models of Polycystic Kidney and Liver Disease"],"prefix":"10.1053","volume":"142","author":[{"given":"Tatyana V.","family":"Masyuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brynn N.","family":"Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J.","family":"Stroope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas M.","family":"Banales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoliy I.","family":"Masyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Gradilone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella Bedekovicsne","family":"Gajdos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Chandok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Bakeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik L.","family":"Ritman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kiyokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2011.11.036_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.gastro.2011.11.036_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOG.0b013e328328f4ff","article-title":"Cholangiociliopathies: genetics, molecular mechanisms and potential therapies","volume":"25","author":"Masyuk","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/j.gastro.2011.11.036_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.dld.2010.01.006","article-title":"Polycystic liver diseases","volume":"42","author":"Onori","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2011.11.036_bib4","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1172\/JCI34922","article-title":"MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease","volume":"118","author":"Lee","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2011.11.036_bib5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3\u2032,5\u2032-cyclic monophosphate","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.11.036_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2796.2006.01743.x","article-title":"Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities","volume":"261","author":"Torres","year":"2007","journal-title":"J Intern Med"},{"key":"10.1053\/j.gastro.2011.11.036_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.22636","article-title":"The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)","volume":"49","author":"Banales","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.11.036_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2011.11.036_bib9","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1053\/j.gastro.2011.11.036_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2010.04.010","article-title":"Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD","volume":"139","author":"Gradilone","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.11.036_bib11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2011.11.036_bib12","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1136\/gut.2008.155721","article-title":"Somatostatin analogues reduce liver volume in polycystic liver disease","volume":"57","author":"van Keimpema","year":"2008","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2011.11.036_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","article-title":"Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease","volume":"68","author":"Ruggenenti","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2011.11.036_bib14","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","article-title":"Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial","volume":"137","author":"van Keimpema","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.11.036_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1146\/annurev.pharmtox.45.120403.100040","article-title":"Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease","volume":"45","author":"Ducruet","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1053\/j.gastro.2011.11.036_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ceb.2006.02.003","article-title":"The when and wheres of CDC25 phosphatases","volume":"18","author":"Boutros","year":"2006","journal-title":"Curr Opin Cell Biol"},{"key":"10.1053\/j.gastro.2011.11.036_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2174\/187152008786847756","article-title":"Cell cycle control by the CDC25 phosphatases","volume":"8","author":"Aressy","year":"2008","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1053\/j.gastro.2011.11.036_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.chembiol.2004.07.007","article-title":"Cdc25 phosphatases and cancer","volume":"11","author":"Kristjansdottir","year":"2004","journal-title":"Chem Biol"},{"key":"10.1053\/j.gastro.2011.11.036_bib19","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0959-8049(99)00156-2","article-title":"Vitamin K3 induces cell cycle arrest and cell death by inhibiting Cdc25 phosphatase","volume":"35","author":"Wu","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.gastro.2011.11.036_bib20","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1158\/1535-7163.MCT-05-0485","article-title":"PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1\/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo","volume":"5","author":"Kar","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1053\/j.gastro.2011.11.036_bib21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2174\/187152008786847738","article-title":"Is Cdc25 a druggable target?","volume":"8","author":"Lazo","year":"2008","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1053\/j.gastro.2011.11.036_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.canlet.2010.06.005","article-title":"Inhibition of androgen receptor and Cdc25A phosphatase as a combination targeted therapy in molecular apocrine breast cancer","volume":"298","author":"Naderi","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1053\/j.gastro.2011.11.036_bib23","first-page":"45","article-title":"The utility of vitamin K3 (menadione) against pancreatic cancer","volume":"28","author":"Osada","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1053\/j.gastro.2011.11.036_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10637-005-6731-2","article-title":"Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy","volume":"23","author":"Lim","year":"2005","journal-title":"Invest New Drugs"},{"key":"10.1053\/j.gastro.2011.11.036_bib25","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1158\/0008-5472.CAN-06-4815","article-title":"Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice","volume":"67","author":"Ray","year":"2007","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2011.11.036_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/sj.ki.5002294","article-title":"A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation","volume":"72","author":"Woollard","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2011.11.036_bib27","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0002-9440(10)63427-X","article-title":"Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease","volume":"165","author":"Masyuk","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2011.11.036_bib28","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2353\/ajpath.2010.090658","article-title":"Hepato-renal pathology in pkd2ws25\/\u2212 mice, an animal model of autosomal dominant polycystic kidney disease","volume":"176","author":"Stroope","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2011.11.036_bib29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2353\/ajpath.2008.080125","article-title":"Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease","volume":"173","author":"Banales","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2011.11.036_bib30","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.lfs.2004.02.011","article-title":"Inhibition of the development of metastases by dietary vitamin C:K3 combination","volume":"75","author":"Taper","year":"2004","journal-title":"Life Sci"},{"key":"10.1053\/j.gastro.2011.11.036_bib31","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0006-2952(02)00904-8","article-title":"Autoschizis: a novel cell death","volume":"63","author":"Jamison","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/j.gastro.2011.11.036_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrc2169","article-title":"CDC25 phosphatases in cancer cells: key players?","volume":"7","author":"Boutros","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.gastro.2011.11.036_bib33","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0024-3205(03)00188-7","article-title":"Differential effects of two growth inhibitory K vitamin analogs on cell cycle regulating proteins in human hepatoma cells","volume":"72","author":"Markovits","year":"2003","journal-title":"Life Sci"},{"key":"10.1053\/j.gastro.2011.11.036_bib34","doi-asserted-by":"crossref","first-page":"31838","DOI":"10.1074\/jbc.M303604200","article-title":"Regulation of Cdc25A half-life in interphase by cyclin-dependent kinase 2 activity","volume":"278","author":"Ducruet","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.gastro.2011.11.036_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/pros.10292","article-title":"Activation of the Raf-1\/MEK\/Erk kinase pathway by a novel Cdc25 inhibitor in human prostate cancer cells","volume":"58","author":"Nemoto","year":"2004","journal-title":"Prostate"},{"key":"10.1053\/j.gastro.2011.11.036_bib36","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.4161\/cbt.5.10.3223","article-title":"H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK","volume":"5","author":"Kar","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1053\/j.gastro.2011.11.036_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1517\/13543771003623232","article-title":"Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review","volume":"20","author":"Lavecchia","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"10.1053\/j.gastro.2011.11.036_bib38","first-page":"713","article-title":"Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo","volume":"26","author":"Hitomi","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1053\/j.gastro.2011.11.036_bib39","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1021\/bi900152k","article-title":"Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel mechanism of its antiproliferative activity","volume":"48","author":"Acharya","year":"2009","journal-title":"Biochemistry"},{"key":"10.1053\/j.gastro.2011.11.036_bib40","first-page":"303","article-title":"The anticancer effects of vitamin K","volume":"8","author":"Lamson","year":"2003","journal-title":"Altern Med Rev"},{"key":"10.1053\/j.gastro.2011.11.036_bib41","first-page":"111","article-title":"Novel agents on the horizon for cancer therapy","volume":"59","author":"Ma","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.gastro.2011.11.036_bib42","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1248\/bpb.31.1270","article-title":"An attempt to evaluate the effect of vitamin K3 using as an enhancer of anticancer agents","volume":"31","author":"Matzno","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1053\/j.gastro.2011.11.036_bib43","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2174\/187152008786847684","article-title":"CDC25A: a rebel within the CDC25 phosphatases family?","volume":"8","author":"Fernandez-Vidal","year":"2008","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1053\/j.gastro.2011.11.036_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1124\/mol.106.028589","article-title":"Independent mechanistic inhibition of cdc25 phosphatases by a natural product caulibugulone","volume":"71","author":"Brisson","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1053\/j.gastro.2011.11.036_bib45","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature05348","article-title":"Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine","volume":"444","author":"Bukanov","year":"2006","journal-title":"Nature"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508511016337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508511016337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:39:36Z","timestamp":1762162776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508511016337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0016508511016337"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2011.11.036","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Cdc25A Suppresses Hepato-renal Cystogenesis in Rodent Models of Polycystic Kidney and Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2011.11.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}